Are there any notable differences in the relationship status of e-cigarette users compared to non-users?4 answersThere is no information available in the provided abstracts regarding the relationship status of e-cigarette users compared to non-users.
Compounds generated from e-cigarettes?5 answersCompounds generated from e-cigarettes include carbonyl compounds such as formaldehyde, acetaldehyde, acrolein, glyoxal, and methyl glyoxal. These carbonyl compounds are mainly produced through the oxidation of e-liquid when it comes into contact with the heating element in the e-cigarette. Other compounds detected in e-cigarette aerosols include nicotine, particles (including fine and nanoparticles), volatile organic compounds (VOCs) such as benzene and toluene, and trace elements. The concentrations of these compounds can vary depending on factors such as the type of e-liquid, battery voltage, and puffing behavior. It is important for e-cigarette users to be aware that hazardous substances are generated even within recommended electric power limits, and that the concentrations of these compounds can be higher than those found in traditional cigarettes. Continuous monitoring and risk management of e-cigarettes are necessary to protect public health.
How is nicotine metabolized?5 answersNicotine is primarily metabolized in the body by the cytochrome P450 (CYP) enzyme family, specifically the CYP2A6 isoform. This enzyme converts nicotine into cotinine, and further metabolizes cotinine into trans-3'-hydroxycotinine. Other metabolites of nicotine include cotinine-N-oxide, nornicotine, norcotinine, 4-oxo-4-(3-pyridyl)-butanoic acid, 4-hydroxy-4-(3-pyridyl)-butanoic acid, and nicotine-N'-oxide. The metabolism of nicotine can be influenced by various factors such as genetic variations in the CYP2A6 gene, diet, age, sex, use of estrogen-containing hormone preparations, pregnancy, kidney disease, other medications, and smoking itself. The measurement of cotinine in biological samples, such as blood, urine, saliva, hair, or nails, is commonly used as a biomarker for nicotine intake.
What are the ingredients of e-cigarette liquids?5 answersE-cigarette liquids contain a variety of ingredients including propylene glycol, glycerin, nicotine, and flavoring ingredients. Some e-liquids also contain cannabinoids such as Δ 8 -Tetrahydrocannabinol (Δ 8 -THC), Dronabinol (aka Δ 9 -THC), and Hexahydrocannabinol (HHC). Other compounds that have been identified in e-liquids include volatile organic compounds, tobacco-specific nitrosamines, polycyclic aromatic hydrocarbons, and heavy metals. It is important to note that the composition of e-liquids can vary between manufacturers and there is a lack of robust oversight of ingredients.
How do e-cigarettes affect pedestrians?4 answersE-cigarettes can affect pedestrians by exposing them to high levels of fine and ultrafine particles, similar to tobacco cigarettes. The chemical compositions of e-cigarette aerosols include propylene glycol, vegetable glycerin, nicotine, and toxic substances such as aldehydes and heavy metals. Bystanders may experience respiratory tract irritation from exposure to propylene glycol and glycerol, and systemic effects of nicotine if nicotine-containing e-liquid is used, including palpitations and an increase in systolic blood pressure. Additionally, the presence of tobacco-specific nitrosamines (TSNAs) in some e-liquids may increase the risk of tumors for bystanders. The use of e-cigarettes also increases fine particle air pollution and levels of potentially carcinogenic compounds in indoor environments. In response to these health risks, some jurisdictions have implemented bans on e-cigarette use in public indoor spaces and open spaces.
Is there a difference in nicotine levels after using different nicotine products?3 answersThere is a difference in nicotine levels after using different nicotine products. A study by Scherer et al. found that the average daily nicotine dose was higher for smokers of combustible cigarettes (CCs) and oral tobacco (OT) compared to users of electronic cigarettes (ECs), heated tobacco products (HTP), and nicotine replacement therapy (NRT) products. Another study by Rostami et al. used a physiologically based pharmacokinetic (PBPK) model to simulate nicotine pharmacokinetics (PK) and found that different tobacco products, including cigarettes, smokeless tobacco, and electronic nicotine delivery systems, have product-specific descriptions of nicotine flux into plasma. Additionally, a study by Mello et al. compared plasma nicotine levels and subjective reports of "high" in nicotine-dependent individuals and found that smoking a high-nicotine cigarette resulted in significantly greater plasma nicotine levels compared to intravenous (IV) nicotine administration, but subjective reports of "high" did not differ significantly between the two. Therefore, the type of nicotine product used can affect the levels of nicotine in the body.